ARTICLE | Company News
RiboGene other research news
October 30, 1995 8:00 AM UTC
The Hayward, Calif., company received a $750,000 Phase II SBIR grant to develop antifungal drugs. The two-year grant will be used to support RiboGene's approach to the discovery and development of dru...